PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2133
https://www.valueinhealthjournal.com/article/S1098-3015(12)03847-8/fulltext
Title :
PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03847-8&doi=10.1016/j.jval.2012.08.2133
First page :
A426
Section Title :
Cancer
Open access? :
No
Section Order :
788